Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

6.59
Delayed Data
As of Mar 05
 +0.29 / +4.60%
Today’s Change
5.06
Today|||52-Week Range
13.18
-5.86%
Year-to-Date

Today’s Trading

Previous close6.30
Today’s open6.30
Day’s range6.29 - 6.68
Volume418,281
Average volume (3 months)673,053
Market cap$98.8M
Dividend yield--
Data as of 4:00pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)+33.68%
Earnings growth (this year)-153.33%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...-0.09-1.80%
LPCNLipocine Inc+0.26+3.27%
NERVMinerva Neuroscience...+0.38+7.31%
ITEKInotek Pharmaceutica...-0.00-0.08%
Data as of 3:59pm ET, 03/05/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$4.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account